spacer
home > > summer 2009 > epro excellence
PUBLICATIONS


ePRO Excellence

Clinical trial sponsors can reap many rewards from collecting patient reported outcomes electronically in multinational clinical trials. Advantages include significant improvements in clinic and subject compliance, data quality, data access and monitoring, as well as reduced staff and subject burden. Yet, as many know, ePRO can also present challenges. By understanding some of the important ePRO best practices, however, sponsors can overcome or bypass the major challenges, and then can more easily realise the promises and benefits that ePRO can offer.

BRIEF SUMMARY OF THE CHALLENGES

One of the major challenges a sponsor faces when using ePRO in multinational trials is ensuring the quality and reliability of the ePRO systems and data files. After all, even small problems with the systems or data can sometimes damage credibility, which can lead to decreased system usage, increased enrolment, queries, and other trial costs, and at worst, the discrediting of all the ePRO data.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Joy Hebert is a co-founder and Chief Operating Officer of .assisTek (formerly Assist Technologies), the global leader in ePROs on touch-screen tablets. Joy has worked in healthcare informatics for 30 years. For the last 15 years she has managed the development and implementation of ePRO systems in clinical studies worldwide.
spacer
Joy Hebert
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection Established platform technology to reliably scale target molecules Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source
More info >>

White Papers

Clinical Trial Labelling More Than Just Labels

Faubel & Co. Nachfolger GmbH

Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >>

 
Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement